These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17919703)

  • 1. The GILL study: glycerin-induced local reactions in immunotherapy.
    Calabria CW; Coop CA; Tankersley MS
    J Allergy Clin Immunol; 2008 Jan; 121(1):222-6. PubMed ID: 17919703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy.
    Calabria CW; Coop CA; Tankersley MS
    J Allergy Clin Immunol; 2009 Oct; 124(4):739-44. PubMed ID: 19767075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local reactions during allergen immunotherapy do not require dose adjustment.
    Tankersley MS; Butler KK; Butler WK; Goetz DW
    J Allergy Clin Immunol; 2000 Nov; 106(5):840-3. PubMed ID: 11080704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction.
    Kelso JM
    Ann Allergy Asthma Immunol; 2004 Feb; 92(2):225-7. PubMed ID: 14989390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy.
    Roy SR; Sigmon JR; Olivier J; Moffitt JE; Brown DA; Marshall GD
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):82-6. PubMed ID: 17650835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose adjustment practices among allergists for local reactions to immunotherapy.
    Coop CA; Tankersley MS
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):77-81. PubMed ID: 17650834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient perceptions regarding local reactions from allergen immunotherapy injections.
    Coop CA; Tankersley MS
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):96-100. PubMed ID: 18681091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local reactions from subcutaneous allergen immunotherapy.
    Coop CA
    Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain and dermal reaction caused by injected glycerin in immunotherapy solutions.
    Van Metre TE; Rosenberg GL; Vaswani SK; Ziegler SR; Adkinson NF
    J Allergy Clin Immunol; 1996 May; 97(5):1033-9. PubMed ID: 8626978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen stability of testing/treatment boards and immunotherapy vials with various diluents.
    Nida A; Leatherman B; Plunkett G; Mire B
    Int Forum Allergy Rhinol; 2015 Nov; 5(11):1028-35. PubMed ID: 26153653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venom immunotherapy reduces large local reactions to insect stings.
    Golden DB; Kelly D; Hamilton RG; Craig TJ
    J Allergy Clin Immunol; 2009 Jun; 123(6):1371-5. PubMed ID: 19443022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The REPEAT study: recognizing and evaluating periodic local reactions in allergen immunotherapy and associated systemic reactions.
    Calabria CW; Stolfi A; Tankersley MS
    Ann Allergy Asthma Immunol; 2011 Jan; 106(1):49-53. PubMed ID: 21195945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How's my dosing? A one-step, math-free guide for comparing your clinic's maintenance immunotherapy doses to current practice parameter recommendations.
    Grier TJ
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):201-5. PubMed ID: 22374205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.
    Horak F; Zieglmayer P; Zieglmayer R; Lemell P; Devillier P; Montagut A; Mélac M; Galvain S; Jean-Alphonse S; Van Overtvelt L; Moingeon P; Le Gall M
    J Allergy Clin Immunol; 2009 Sep; 124(3):471-7, 477.e1. PubMed ID: 19647862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The mechanisms of allergen-specific immunotherapy more clear].
    Rak S
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1935-7. PubMed ID: 18681375
    [No Abstract]   [Full Text] [Related]  

  • 18. [The estimation of treatment of Hymenoptera venoms allergy in children].
    Botulińska E; Piotrowska T; Korol D; Swiebocka E; Hofman J
    Pol Merkur Lekarski; 2006 Sep; 21(123):232-4. PubMed ID: 17163183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Math-free guides for glycerin and allergens at variable subcutaneous injection volumes: How's my dosing? Update.
    Grier TJ; Converse LM; Rekkerth DJ; Renahan KE
    Ann Allergy Asthma Immunol; 2016 May; 116(5):455-60. PubMed ID: 27017565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urticaria in relation to mite sensitivity and immunotherapy with Injection dermatophagoidei farinae].
    Xing DR; Wen TH; Yu YL; Wei ZP; Li YM; Han T
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):422-7. PubMed ID: 19288915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.